ROIVRoivant Sciences Ltd.

$35.42+136% 1Y

Is the price fair?

What ROIV's price assumes

Price / book
5.80

Price / book · as of 2026-Q2

Details›
Price / bookas of 2026-Q2
5.80
EV / EBIToperating margin −7915%: the multiple describes the denominator
not meaningful
Market capitalisation
$24.5B

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.